FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2262857650> ?p ?o ?g. }

• W2262857650 endingPage "2562" @default.
• W2262857650 startingPage "2562" @default.
• W2262857650 abstract "2562 Background: Dendritic cells may be responsible for awakening immunocompetence in cancer patients (pts). They can be administered therapeutically after loading with tumor antigens (immature dendritic cells, iDC), when it is hypothesized that they migrate to regional lymph nodes and mature in vivo, or they can be administered after in vitro maturation (mature dendritic cells, mDC). These two therapeutic modalities were compared in 19 pts with advanced melanoma or renal cell carcinoma (RCC) using iDC or mDC pulsed with autologous tumor lysate (ATL) and keyhole limpet hemocyanin (KHL), administered intradermally (id). Methods: DC were obtained from adherent mononuclear cells cultured with IL-4 and GM-CSF.ATL and KLH were added on the 6th day. On the 7th day iDC were used to vaccinate 9 pts, while mDC, obtained by a further 48-h culture with IL-1β, IL-6, TNFα and PGE2, were used in 10 pts. Results: Of the 9 pts (8 melanoma,1 RCC) treated with iDC, 4 showed stable disease (SD) of 19, 6, 6, 6 months' duration and 5 progressed (P). Four of the 9 pts had weak delayed-type hypersensitivity (DTH) skin reactions for KLH or ATL. Of the 10 pts (9 melanoma and 1 RCC) treated with mDC, there was 1 complete response (CR) (abdominal lymph nodes) of 10+ months' duration, with positive DTH for both ATL and KLH and onset of vitiligo,1 partial response (PR) (lung and lymph nodes) of 3 months' duration, with subsequent development of brain metastases, 1 mixed response (MR) (skin and lymph nodes) lasting 6 months with positive DTH for both ATL and KLH and subsequent development of brain metastases, 3 SD of 9 (RCC patient), 9 and 7+ months' duration with positive DTH for KLH (1 pt progressed with brain metastases), and 4 P (1 brain metastases), all with negative DTH for ATL. Conclusions: Intradermally administered mDC appear to have a more important therapeutic potential than iDC for anticancer vaccination. Results could be optimized by improving times and modalities of in vitro maturation, with a more specific selection of pts (more immunoresponsive and/or with minimal residual disease) and perhaps with chemoprevention of brain metastases. Partially financed by Ministry of Health Research Projects 2000, n. 352 and 2002, n.234. No significant financial relationships to disclose." @default.
• W2262857650 created "2016-06-24" @default.
• W2262857650 creator A5033819353 @default.
• W2262857650 creator A5042624180 @default.
• W2262857650 creator A5044347261 @default.
• W2262857650 creator A5051351435 @default.
• W2262857650 creator A5055462054 @default.
• W2262857650 creator A5058171569 @default.
• W2262857650 creator A5071634163 @default.
• W2262857650 creator A5075055655 @default.
• W2262857650 date "2004-07-15" @default.
• W2262857650 modified "2023-09-27" @default.
• W2262857650 title "Comparison between immature and mature dendritic cells in a vaccination trial" @default.
• W2262857650 doi "https://doi.org/10.1200/jco.2004.22.14_suppl.2562" @default.
• W2262857650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28015252" @default.
• W2262857650 hasPublicationYear "2004" @default.
• W2262857650 type Work @default.
• W2262857650 sameAs 2262857650 @default.
• W2262857650 citedByCount "1" @default.
• W2262857650 countsByYear W22628576502013 @default.
• W2262857650 crossrefType "journal-article" @default.
• W2262857650 hasAuthorship W2262857650A5033819353 @default.
• W2262857650 hasAuthorship W2262857650A5042624180 @default.
• W2262857650 hasAuthorship W2262857650A5044347261 @default.
• W2262857650 hasAuthorship W2262857650A5051351435 @default.
• W2262857650 hasAuthorship W2262857650A5055462054 @default.
• W2262857650 hasAuthorship W2262857650A5058171569 @default.
• W2262857650 hasAuthorship W2262857650A5071634163 @default.
• W2262857650 hasAuthorship W2262857650A5075055655 @default.
• W2262857650 hasConcept C137061746 @default.
• W2262857650 hasConcept C142724271 @default.
• W2262857650 hasConcept C147483822 @default.
• W2262857650 hasConcept C150903083 @default.
• W2262857650 hasConcept C202751555 @default.
• W2262857650 hasConcept C203014093 @default.
• W2262857650 hasConcept C207001950 @default.
• W2262857650 hasConcept C2776727803 @default.
• W2262857650 hasConcept C2777658100 @default.
• W2262857650 hasConcept C2777701055 @default.
• W2262857650 hasConcept C2778170410 @default.
• W2262857650 hasConcept C2779720271 @default.
• W2262857650 hasConcept C502942594 @default.
• W2262857650 hasConcept C55493867 @default.
• W2262857650 hasConcept C71924100 @default.
• W2262857650 hasConcept C86803240 @default.
• W2262857650 hasConcept C8891405 @default.
• W2262857650 hasConceptScore W2262857650C137061746 @default.
• W2262857650 hasConceptScore W2262857650C142724271 @default.
• W2262857650 hasConceptScore W2262857650C147483822 @default.
• W2262857650 hasConceptScore W2262857650C150903083 @default.
• W2262857650 hasConceptScore W2262857650C202751555 @default.
• W2262857650 hasConceptScore W2262857650C203014093 @default.
• W2262857650 hasConceptScore W2262857650C207001950 @default.
• W2262857650 hasConceptScore W2262857650C2776727803 @default.
• W2262857650 hasConceptScore W2262857650C2777658100 @default.
• W2262857650 hasConceptScore W2262857650C2777701055 @default.
• W2262857650 hasConceptScore W2262857650C2778170410 @default.
• W2262857650 hasConceptScore W2262857650C2779720271 @default.
• W2262857650 hasConceptScore W2262857650C502942594 @default.
• W2262857650 hasConceptScore W2262857650C55493867 @default.
• W2262857650 hasConceptScore W2262857650C71924100 @default.
• W2262857650 hasConceptScore W2262857650C86803240 @default.
• W2262857650 hasConceptScore W2262857650C8891405 @default.
• W2262857650 hasIssue "14_suppl" @default.
• W2262857650 hasLocation W22628576501 @default.
• W2262857650 hasOpenAccess W2262857650 @default.
• W2262857650 hasPrimaryLocation W22628576501 @default.
• W2262857650 hasRelatedWork W148881103 @default.
• W2262857650 hasRelatedWork W1599996543 @default.
• W2262857650 hasRelatedWork W1974496092 @default.
• W2262857650 hasRelatedWork W2043505088 @default.
• W2262857650 hasRelatedWork W2048960710 @default.
• W2262857650 hasRelatedWork W2064770085 @default.
• W2262857650 hasRelatedWork W2066429436 @default.
• W2262857650 hasRelatedWork W2076194195 @default.
• W2262857650 hasRelatedWork W2328036837 @default.
• W2262857650 hasRelatedWork W2943059971 @default.
• W2262857650 hasVolume "22" @default.
• W2262857650 isParatext "false" @default.
• W2262857650 isRetracted "false" @default.
• W2262857650 magId "2262857650" @default.
• W2262857650 workType "article" @default.